<DOC>
	<DOCNO>NCT00836576</DOCNO>
	<brief_summary>The objective randomized , single-dose , two-way crossover evaluation compare oral bioavailability test benazepril HCl formulation ( TEVA Pharmaceutical Industries Ltd. ) equivalent oral dose commercially available benazepril HCl ( Lotensin® , Novartis Pharmaceuticals Corporation ) test population 40 adult fasting condition .</brief_summary>
	<brief_title>Benazepril HCl 40 mg Tablets , Fasting</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Benazepril</mesh_term>
	<criteria>Sex : Male Female ; similar proportion prefer . Age : At least 18 year . Subjects must minimum weight least 110 pound . Qualifying subject must good health physical condition determine medical history , complete physical examination , laboratory test , obtain within four ( 4 ) week prior study start . The subject may history significant past illness expect affect investigation . The normal status subject confirm follow procedure : 1 . Laboratory Tests : Hemoglobin , hematocrit , RBC , WBC , differential count , serum electrolyte ( Na , K , Cl ) , fast blood glucose , BUN , bilirubin , creatinine , AST , ALT , LDH , alkaline phosphatase , urinalysis . HIV , Hepatitis B , Hepatitis C , drug abuse test do screening purpose . Laboratory value great ± 20 % normal range qualify unless specifically accept ( comment ) Principal Investigator . Results HIC , Hepatitis B , Hepatitis C , drug abuse must negative nonreactive subject qualify study . Additional drug abuse test do checkin period . Tests negative requirement dose . Female subject urine pregnancy test do screen prior study period checkin . 2 . Electrocardiogram : A 12lead electrocardiogram obtain subject . The original tracing , plus interpretation , include case report form packet . Subjects must read sign Consent Form . Subjects comply inclusion criterion must exclude study . In addition one condition list exclude subject study : 1 . History treatment alcoholism , drug abuse , substance abuse within past 24 month . 2 . History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . 3 . History treatment asthma within past five ( 5 ) year . 4 . History treatment gastrointestinal disorder within past five ( 5 ) year . 5 . History neutropenia . 6 . History hyperkalemia . 7 . History angioedema . 8 . History impaired renal function . 9 . History persistent nonproductive cough . 10 . Females pregnant lactating . 11 . History hypersensitivity benazepril HCl , angiotensinconverting enzyme ( ACE ) inhibitor . Conditions upon screen might contraindicate require caution use administration benazepril HCl , include : 1 . Sitting systolic blood pressure 90 mmHg , diastolic pressure 50 mmHg . 2 . Heart rate le 50 beat per minute 5minute rest seat position . Inability read and/or sign consent form . Treatment investigational drug four ( 4 ) week prior enrollment study . Subjects donate blood within four ( 4 ) week prior entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>